Solve your dosage form and delivery challenges with Lonza Capsule Application Lab
Pharmaceutical companies are under constant pressure to create improved, lower risk and cost-effective drugs faster. The Lonza Capsule Application Lab services can augment your existing research and development to meet stringent requirements.
Bristol Myers Squibb licenses amyloid-beta antibody programme
By Catherine Eckford (European Pharmaceutical Review)
Adopting AI for R&D in 2025 – what needs to be addressed?
By Dr Vladimir Makarov (The Pistoia Alliance), European Pharmaceutical Review
CHMP recommends novel long-acting HIV treatment
By Catherine Eckford (European Pharmaceutical Review)
Novo Nordisk investing in rare disease with major new manufacturing site
By Catherine Eckford (European Pharmaceutical Review)
Adopting AI for R&D in 2025 – what needs to…
By Dr Vladimir Makarov (The Pistoia Alliance), European Pharmaceutical Review